13F-HR filed by Propel Bio Management, LLC
Propel Bio Management, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-13, with 28 holding rows worth $171,807,368.
- Accession
- 0001829126-24-003275
- Filer
- CIK 1969764
- Filed
- 2024-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 29 entries on the cover page, a total value of $171,807,368 stated on the cover page (in dollars after the unit check, H1), rows summing to $171,807,368 with VALUE read as dollars as filed, 13F file number 028-23914. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSimplify Asset Management Inc.028-20937
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | 03828A101 | Common Stock | 6,111,906 | $41,560,961 | dollars as filed | |
| SIMPLIFY EXCHANGE TRADED FUN | 82889N632 | ENHANCED INM ETF | 1,492,581 | $27,978,962 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 2,087,139 | $16,571,884 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 43,032 | $11,491,265 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 2,453,092 | $11,149,303 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 869,927 | $9,238,625 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 327,752 | $8,279,016 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 750,000 | $7,080,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 178,500 | $4,555,320 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 270,664 | $4,471,369 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 594,174 | $4,337,470 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,492,792 | $4,090,250 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 130,000 | $2,772,900 | dollars as filed | |
| TELESAT CORP | 879512309 | CL A & CL B SHS | 290,781 | $2,500,717 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 56,359 | $2,265,632 | dollars as filed | |
| iShares MBS ETF | 464288588 | SHS | 22,400 | $2,070,208 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 83,259 | $1,981,564 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 70,000 | $1,758,400 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 180,100 | $1,628,104 | dollars as filed | |
| KAYNE ANDERSON ENERGY | 486606106 | COM | 147,033 | $1,471,800 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 195,000 | $1,101,750 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 260,000 | $897,000 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 535,000 | $743,650 | dollars as filed | |
| EIGER BIOPHARMACEUTICALS | 28249U204 | COMM | 146,381 | $731,905 | dollars as filed | |
| iShares iBoxx Inv Grade Corporate Bond ETF | 464287242 | SHS | 4,456 | $485,348 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 850,000 | $351,475 | dollars as filed | |
| FIDELITY INV MMTRSY 1 680 | X9USDFIDT | COMM | 211,541 | $211,541 | dollars as filed | |
| CHINOOK THERAPEUTICS CVR | 169CVR016 | RIG | 79,357 | $30,949 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001829126-24-003275 | this filing | 2024-05-13 | acceptance time not in the bulk data set |